Azitra, Inc.
AZTR
Rank in Stocks
#31033
Azitra, Inc. is a pre-clinical biopharmaceutical company focused on developing... Azitra, Inc. is a pre-clinical biopharmaceutical company focused on developing precise treatments for various dermatological conditions. They innovate by utilizing engineered proteins and live biotherapeutic products to address skin diseases. The company's pipeline features several key therapeutic candidates: ATR-12: A genetically modified strain of S. epidermidis intended to treat Netherton syndrome, a specific skin disorder. ATR-04: Another modified S. epidermidis strain, designed to alleviate the papulopustular rash commonly experienced by cancer patients undergoing epidermal growth factor receptor inhibitor therapy. ATR-01: An engineered recombinant human filaggrin protein developed for the treatment of ichthyosis vulgaris, another dermatological ailment. Founded in 2014, Azitra, Inc. operates from its headquarters in Branford, Connecticut.
Share Price
$0.644
Last synced: 2026-11-09
Market Cap
$3.90M
Change (1 day)
-12.08%
Change (1 year)
62.22%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Azitra, Inc. (AZTR)
Category
Healthcare
EPS for Azitra, Inc. (AZTR)
EPS as of June 2026 TTM: $-13.00
According to Azitra, Inc.'s latest financial reports, its current EPS (TTM) is $-13.00. At the end of 2025 the company had an EPS of $-22.50, an increase over its 2024 EPS of $-157.80.
EPS history for Azitra, Inc. from 2021 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-13.00 | -42.22% |
| 2025 | $-22.50 | -85.74% |
| 2024 | $-157.80 | -92.44% |
| 2023 | $-2.09K | -6.11% |
| 2022 | $-2.22K | 14.87% |
| 2021 | $-1.94K | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -220.46% |
US
|
|
| $-7.07 | -45.62% |
US
|
|
| $-5.29 | -59.31% |
AU
|
|
| $12.88 | -199.08% |
BE
|
|
| $21.56 | -265.85% |
NL
|
Questions about Azitra, Inc.'s earnings per share (EPS)
What is Azitra, Inc.'s earnings per share (EPS)?
Azitra, Inc.'s earnings per share (EPS) over the last twelve months is $-13.00, as of Jun 2026.
What was Azitra, Inc.'s earnings per share (EPS) in 2025?
In 2025, Azitra, Inc.'s earnings per share (EPS) was $-22.50, compared with $-157.80 in 2024.
How has Azitra, Inc.'s earnings per share (EPS) changed since 2021?
From 2021 to 2025, Azitra, Inc.'s earnings per share (EPS) was highest in 2025 ($-22.50) and lowest in 2022 ($-2.22K).
How does Azitra, Inc.'s earnings per share (EPS) compare with similar companies?
Azitra, Inc.'s earnings per share (EPS) ($-13.00) is lower than that of all 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.